Sharon R Lewin

34PUBLICATIONS
177CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 21, 2026
In vivo effect of anti-PD-1 on HIV-specific CD8+T-cells in men with HIV.

|Jul 01, 2026
Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4+ T cells.

|May 12, 2026
Community Perceptions Regarding use of HIV Molecular Epidemiology for Public Health in Victoria, Australia: Qualitative Findings.

|Feb 25, 2026
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferation.

Jared Stern, Rory A Shepherd, Youry Kim

|Feb 12, 2026
Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy.

Aarthi Talla, Joao L L C Azevedo, Muhammad Bilal Latif

|Jan 29, 2026
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir.

Youry Kim, Jenny L Anderson, Carolin Tumpach

Pageof 6

Frequent Collaborators

4 joint publications

Michael Roche

4 joint publications

Nicolas Chomont

4 joint publications

Steven G Deeks

4 joint publications

Paul U Cameron